Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, once again, rather modest. We plan to catch up on all sorts of reading, hang with our short person, and forage for valuable sonic treasures at a downsizing event. And what about you? It is never too late to plan a winter break. You might want to catch up on some of those moving pictures you meant to see. Or you could spend all weekend preparing for that football game. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The Philippine government believes that the Sanofi (SNY) dengue vaccine may be connected to three deaths in the country, The Asahi Shimbun writes. Sanofi revealed in November that Dengvaxia, the world’s first dengue vaccine, might increase the risk of severe disease in people who had never been exposed to the virus. Some experts believe at least one other vaccine, which is being developed by Takeda Pharmaceuticals (TKPYY), may see a similar problem when results of its ongoing, eight-country Phase 3 trial are available, STAT explains.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.